GW Pharmaceuticals Falls 7% Following Disappointing Sativex Trial

By: via Benzinga
Shares of GW Pharmaceuticals PLC (ADR) (NASDAQ: GWPH) fell in Thursday’s premarket following disappointing results from its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.